Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination DMARDs vs Methotrexate in Early Rheumatoid Arthritis
NCT02644499Phase 4Completed
- Sponsor
- JIPMER
- Start
- Dec 2015
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of leflunomide and hydroxychloroquine in rheumatoid arthritis (RA) (2 arms), sponsored by JIPMER. Primary endpoints: European League Against Rheumatism response criteria at 3 months and Indian Health Assessment Questionnaire at 3 months. Started Dec 2015; status: completed.
02
Drugs
leflunomidehydroxychloroquine
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02644499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02644499.